KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Globus Medical (GMED) Equity Average (2016 - 2025)

Globus Medical's Equity Average history spans 14 years, with the latest figure at $4.5 billion for Q4 2025.

  • For Q4 2025, Equity Average rose 8.8% year-over-year to $4.5 billion; the TTM value through Dec 2025 reached $4.5 billion, up 8.8%, while the annual FY2025 figure was $4.4 billion, 7.04% up from the prior year.
  • Equity Average reached $4.5 billion in Q4 2025 per GMED's latest filing, up from $4.3 billion in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $4.5 billion in Q4 2025 to a low of $1.5 billion in Q1 2021.
  • Average Equity Average over 5 years is $2.9 billion, with a median of $2.5 billion recorded in 2023.
  • Peak YoY movement for Equity Average: surged 126.71% in 2023, then increased 0.75% in 2024.
  • A 5-year view of Equity Average shows it stood at $1.7 billion in 2021, then grew by 4.36% to $1.8 billion in 2022, then soared by 126.71% to $4.1 billion in 2023, then increased by 0.75% to $4.1 billion in 2024, then grew by 8.8% to $4.5 billion in 2025.
  • Per Business Quant, the three most recent readings for GMED's Equity Average are $4.5 billion (Q4 2025), $4.3 billion (Q3 2025), and $4.2 billion (Q2 2025).